Bearish
2
Neutral
7
Bullish
5
Bearish
2
Neutral
7
Bullish
37
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
| Company | Weightage (%) |
| Sun Pharmaceutical Industries Ltd. | 13.20% |
| Divis Laboratories Ltd. | 6.00% |
| Cipla Ltd. | 5.90% |
| Dr Reddys Laboratories Ltd. | 5.80% |
| Apollo Hospitals Enterprise Ltd. | 5.60% |
| Max Healthcare Institute Ltd. | 5.50% |
| Lupin Ltd. | 4.10% |
| Fortis Healthcare Ltd. | 3.50% |
| Torrent Pharmaceuticals Ltd. | 3.20% |
| Laurus Labs Ltd. | 2.90% |
40
0.23%
—
—
Low Risk
0.15
—
40.75
55.39
0.933
—
Bullish
78.63
51.81
48.84
Allocation
The current market price of Motilal Oswal S&P BSE Healthcare ETF is ₹54.49. ETF prices fluctuate during market hours based on demand, supply, and movements in the underlying index or assets.
Motilal Oswal S&P BSE Healthcare ETF, managed by Motilal Oswal Asset Management Company Limited, is a sector-specific ETF targeting BSE Healthcare TRI total returns before expenses, subject to tracking error. Its objective follows the BSE Healthcare Total Return Index, with management shared by Swapnil Mayekar, managing since Jul 2022, and Dishant Mehta, managing since Oct 2024. Portfolio exposure is concentrated in Pharmaceuticals & Biotechnology at 75.6% and Healthcare Services at 23.7%; Sun Pharmaceutical Industries leads at 13.2%, indicating pronounced sector concentration. Performance records a 1Y return of +5.4% and 3Y CAGR of +20.2%, showing stronger annualised medium-term growth than the latest one-year outcome on reported measures. As of Jan 2026, AUM was ₹40.2 Cr, versus monthly average ₹39.5 Cr; expense ratio is 0.23%, with operational details otherwise limited in the available data.
Motilal Oswal S&P BSE Healthcare ETF is designed to track BSE Healthcare Total Return Index, allowing investors to gain exposure to its underlying securities through a single investment.
The expense ratio of Motilal Oswal S&P BSE Healthcare ETF is 0.23%. This represents the annual fee charged by the fund house for managing the ETF and is deducted from the fund’s assets.
The Assets Under Management (AUM) of Motilal Oswal S&P BSE Healthcare ETF is approximately ₹40.21. AUM reflects the total market value of assets managed by the ETF and is often used as an indicator of fund size and liquidity.
Motilal Oswal S&P BSE Healthcare ETF is classified under the as per the risk-o-meter defined by the fund house risk category. The risk level depends on the volatility of the underlying index, market conditions, and asset composition of the ETF.
The tracking error of Motilal Oswal S&P BSE Healthcare ETF is depends on how closely the ETF follows its benchmark. Tracking error measures how closely the ETF’s performance matches its benchmark index over time.
Motilal Oswal S&P BSE Healthcare ETF does not currently declare dividends and may reinvest earnings into the fund. Dividend treatment depends on the ETF structure and fund house policy.
Based on available data, Motilal Oswal S&P BSE Healthcare ETF has delivered the following returns: 1-year return: 20.34%. 3-year return: 81.45%. 5-year return: 136.09%. Past performance does not guarantee future results.
Before investing in Motilal Oswal S&P BSE Healthcare ETF, investors generally consider the underlying index, expense ratio, tracking error, risk profile, liquidity, and how the ETF fits within their overall portfolio strategy.
Performance
STEADY PERFORMER
Technicals
Bullish
Risk
—
Liquidity
GOOD
Consistency
GOOD
97.48
▲ 0.55%
30.94
▼ 0.06%
98.30
▼ 0.46%
58.20
▼ 0.65%
32.93
▲ 0.30%
84.29
▲ 1.26%
34.45
▲ 0.73%
72.63
▼ 0.78%
94.20
▲ 1.65%
121.28
▼ 4.95%
37.54
▼ 0.45%
52.92
▼ 0.40%
114.90
▲ 0.21%
36.54
▲ 0.86%
266.61
▼ 0.07%
24.62
▲ 0.78%
17.89
▲ 0.17%
66.42
▼ 0.57%
60.71
▼ 0.03%
159.97
▲ 0.37%
26.80
▲ 1.17%
63.81
▲ 0.47%
216.99
▼ 2.31%
53.02
▼ 0.36%
48.61
▲ 0.58%
65.54
▲ 1.28%
299.00
▼ 1.41%
58.50
▲ 0.39%
152.43
▼ 4.27%
54.49
▲ 1.28%
193.85
▲ 0.00%

AUM
₹ 40 Cr
Expense Ratio
0.23%